drugset / Trial / NCT05484167

Natesto Testosterone Nasal Gel for Hypogonadal Men

NCT05484167

RandomizedCrossoverDouble-blindTreatment

Summary

To determine if testosterone deficient men who are using daily Tadalafil (a phosphodiesterase-5 Inhibitor), will have a significant improvement in erectile function and satisfaction with erectile dysfunction treatment when using on-demand Testosterone Nasal Gel (TNG) prior to sexual activity compared to placebo.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule Intranasal